IFOSFAMIDE-INDUCED ENCEPHALOPATHY: QUALITY CONTROL OF INTRAVENOUS SOLUTION OF METHYLENE BLUE FORMULATED AND PREPARED IN PHARMACY USING A DISPOSABLE CLOSED SYSTEM TRANSFER DEVICE – A CASE REPORT
3PC-036
SMALL-SCALE COMPOUNDING USING A POWDER DISPENSING TOOL FOR INDIVIDUALISED SOLID DOSAGE FORM DRUG DELIVERY
3PC-032
DETERMINATION OF SENSITIVITY THRESHOLD FOR STERILITY ASSAY OF THE BINARY PARENTERAL NUTRITION BAGS BY DIRECT SEEDING
3PC-029
CALCULATION OF ANNUAL ECONOMIC IMPACT OF MANUFACTURING AVASTIN® SYRINGES IN THE AGERELATED MACULAR DEGENERATION TREATMENT IN OUR HOSPITAL
3PC-018
THE ADVANTAGE OF AUTOMATION IN THE PREPARATION OF CHEMOTHERAPY DRUGS FOR THE INTERCEPTION OF ERRORS
3PC-014
STABILITY STUDY OF GENTAMICIN LOCK THERAPY WITH HEPARIN OR CITRATE AS ANTICOAGULANT
3PC-011
HPLC METHOD DEVELOPMENT AND VALIDATION TO DETERMINATE RESORCINOL FOR QUALITY CONTROL IN PHARMACEUTICAL FORMULATIONS
3PC-024
APPLICATION OF A MATRIX RISK TO AN APPROPRIATE COMPOUNDING PROCESS OF AFLIBERCEPT AND RANIBIZUMAB INTRAVITREAL INJECTIONS
3PC-004
AUTOMATION OF PARENTERAL NUTRITION ELABORATION IN A HOSPITAL PHARMACY SERVICE
3PC-005
A NEW PACKAGING OF HYPERTONIC SOLUTION TO OVERCOME AN UNAVAILABLE FORMULATION IN FRANCE
3PC-002
STABILITY OF MIXTURES OF ONDANSETRON AND HALOPERIDOL STORED IN INFUSORS AT DIFFERENT TEMPERATURES
